Gene · 7083
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress. | Mol Biol Rep | 2024 | 38270700 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. | Curr Oncol | 2024 | 38248103 | PubTator, text mining | PubMed |
| Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results. | Hematol Rep | 2024 | 38247994 | PubTator, text mining | PubMed |
| Right upper lobectomy after immunotherapy for primary malignant melanoma of the lung: a case report and literature review. | AME Case Rep | 2024 | 38234360 | PubTator, text mining | PubMed |
| A Novel Model Using Serum Thymidine Kinase 1 and Low-dose Computed Tomography Parameters to Predict Three-year Lung Cancer Risk in People with Pulmonary Nodules: A Retrospective Study. | J Cancer | 2024 | 38213734 | PubTator, text mining | PubMed |
| Orthogonally Sequential Activation of Self-Powered DNAzymes Cascade for Reliable Monitoring of mRNA in Living Cells. | Adv Healthc Mater | 2024 | 38197479 | PubTator, text mining | PubMed |
| Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. | Nat Commun | 2024 | 38191557 | PubTator, text mining | PubMed |
| The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial. | Breast Cancer Res Treat | 2024 | 38175448 | PubTator, text mining | PubMed |
| Feeder-free generation and characterization of endocardial and cardiac valve cells from human pluripotent stem cells. | iScience | 2024 | 38170020 | PubTator, text mining | PubMed |
| Association of thymidine kinase-1 with prostate cancer. | Asian J Surg | 2024 | 38135534 | PubTator, text mining | PubMed |
| Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. | J Vet Intern Med | 2024 | 38088206 | PubTator, text mining | PubMed |
| A binary system based DNA tetrahedron and fluorogenic RNA aptamers for highly specific and label-free mRNA imaging in living cells. | Talanta | 2024 | 38008022 | PubTator, text mining | PubMed |
| Enhancing intracellular mRNA precise imaging-guided photothermal therapy with a nucleic acid-based polydopamine nanoprobe. | Anal Bioanal Chem | 2024 | 38006441 | PubTator, text mining | PubMed |
| Clinical Significance of the TK1-Specific Activity in the Early Detection of Ovarian Cancer. | Oncology | 2024 | 37673047 | PubTator, text mining | PubMed |
| Reclassification of ASFV into 7 Biotypes Using Unsupervised Machine Learning. | Viruses | 2023 | 38257767 | PubTator, text mining | PubMed |
| Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response. | J Clin Med | 2023 | 38202160 | PubTator, text mining | PubMed |
| A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer. | J Clin Med | 2023 | 38202064 | PubTator, text mining | PubMed |
| Controlled Plasma Membrane Delivery of FGFR1 and Modulation of Signaling by a Novel Regulated Anterograde RTK Transport Pathway. | Cancers (Basel) | 2023 | 38136383 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
| Engineered aptamers for molecular imaging. | Chem Sci | 2023 | 38098720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7083/papers?page=8